S. 2823: Family and Medical Insurance Leave Act
The Family and Medical Insurance Leave Act is designed to offer paid family and medical leave benefits to qualifying individuals. Here are the main components of the bill:
Establishment of Office
The bill creates an Office of Paid Family and Medical Leave within the Social Security Administration. This office will manage the program, which includes:
- Determining eligibility for paid leave.
- Disbursing benefits to those who qualify.
Paid Leave Benefits
Eligible individuals can receive financial support that allows them to take time off for family or medical reasons without facing economic hardship. This includes care for a newborn, a family member with a serious health condition, or recuperation from one's own health issues.
Legal Provisions
The bill establishes legal avenues for employees who may face violations of their rights under this new program. Key aspects include:
- Employees can seek damages if their rights are violated.
- Equitable relief measures can be pursued to address violations.
- Covered individuals are entitled to seek compensation for attorney fees related to enforcing their rights under the bill.
Filing Actions and Limitations
The bill specifies certain actions that can be taken in court if violations occur. It also sets limitations on how long individuals have to file claims, ensuring that employees are aware of their rights and can seek recourse in a timely manner.
State Grants
Additionally, the bill includes provisions for granting funds to states that are already providing paid family and medical leave programs. This encourages state-level initiatives to support family leave policies and enhance participation in the federal program.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
39 bill sponsors
-
TrackKirsten E. Gillibrand
Sponsor
-
TrackAngela Alsobrooks
Co-Sponsor
-
TrackTammy Baldwin
Co-Sponsor
-
TrackMichael F. Bennet
Co-Sponsor
-
TrackRichard Blumenthal
Co-Sponsor
-
TrackLisa Blunt Rochester
Co-Sponsor
-
TrackCory A. Booker
Co-Sponsor
-
TrackChristopher A. Coons
Co-Sponsor
-
TrackTammy Duckworth
Co-Sponsor
-
TrackRichard J. Durbin
Co-Sponsor
-
TrackJohn Fetterman
Co-Sponsor
-
TrackRuben Gallego
Co-Sponsor
-
TrackMargaret Wood Hassan
Co-Sponsor
-
TrackMartin Heinrich
Co-Sponsor
-
TrackMazie K. Hirono
Co-Sponsor
-
TrackMark Kelly
Co-Sponsor
-
TrackAndy Kim
Co-Sponsor
-
TrackAmy Klobuchar
Co-Sponsor
-
TrackBen Ray Lujan
Co-Sponsor
-
TrackEdward J. Markey
Co-Sponsor
-
TrackJeff Merkley
Co-Sponsor
-
TrackChristopher Murphy
Co-Sponsor
-
TrackPatty Murray
Co-Sponsor
-
TrackAlex Padilla
Co-Sponsor
-
TrackJack Reed
Co-Sponsor
-
TrackJacky Rosen
Co-Sponsor
-
TrackBernard Sanders
Co-Sponsor
-
TrackBrian Schatz
Co-Sponsor
-
TrackAdam B. Schiff
Co-Sponsor
-
TrackCharles E. Schumer
Co-Sponsor
-
TrackJeanne Shaheen
Co-Sponsor
-
TrackElissa Slotkin
Co-Sponsor
-
TrackTina Smith
Co-Sponsor
-
TrackChris Van Hollen
Co-Sponsor
-
TrackRaphael G. Warnock
Co-Sponsor
-
TrackElizabeth Warren
Co-Sponsor
-
TrackPeter Welch
Co-Sponsor
-
TrackSheldon Whitehouse
Co-Sponsor
-
TrackRon Wyden
Co-Sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Sep. 16, 2025 | Introduced in Senate |
| Sep. 16, 2025 | Read twice and referred to the Committee on Finance. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.